The
global assisted reproductive
technology market is expected to reach USD 29.3 billion by 2022,
according to a new report by Grand View Research Inc. Growing prevalence of
stress and increase in the pollution levels coupled with the changing lifestyle
habits including smoking and drinking are expected to drive the assisted
reproductive technology market over the forecast period.
Growing
incidence rate of male and female infertility due to low sperm count, poor
sperm movement, blocked sperm ducts, and fallopian tubes blockage coupled with
problems in uterus or cervix, respectively is expected to significantly
contribute towards market growth.
Medical
tourism is instrumental in facilitating growing demand of assisted human
reproductive technology. Although, these technologies are widely used in the
developed economies of the U.S. and Canada, entailed high costs render these
services unavailable to every patient. Nations are regulated by stringent laws
and govern the transactions between surrogates, egg donors, and those who are
willing to avail these services.
Countries
such as Czech Republic, Israel, South Africa, and Spain offer good fertility
options. India and Mexico were among the most technologically and economically
viable fertility choices for foreign couples. Success rates as good as other
western nations and with less than half the cost, are few factors spearheading
regional growth.
Browse full research report on Global Assisted Reproductive
Technology Market: http://www.grandviewresearch.com/industry-analysis/assisted-reproductive-technology-market
Further key findings
from the report suggest:
- Fresh
non-donor was the largest ART market procedure segment in 2014. The fact
that fresh eggs and sperms increase the number of successful pregnancies
is expected to drive segment growth over the forecast period.
- Frozen
non-donor is identified as the most lucrative segment of assisted
reproductive technology industry. It is expected to grow at a CAGR of over
5.5% over the forecast period.
- North
America dominated global demand accounting for USD 8.5 billion in 2014.
This is attributed to rising people awareness and acceptance of people
towards gametes preservation and donation, government funding for in vitro
fertilization, and high usage rate of advanced technologies such as
vitrification.
- Asia
Pacific is expected to witness substantial growth over the forecast period
owing to increasing prevalence of obesity and average maternal age in the
emerging markets of India and China.
- The Asia
Pacific Initiative on Reproduction (ASPIRE) task force of clinicians and
scientists are involved in the monitoring and management of fertility and
Assisted Reproductive Technology (ART).
- Key players
of the assisted reproductive technology market include Cosmos Biomedical,
Origio, European Sperm Bank, Cryolab Ltd., Ovascience, Parallabs, Microm
UK Ltd., Irvine Scientific, and Bloom IVF Centre.
Browse more reports of this category by
Grand View Research: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has
segmented the assisted reproductive technology market on the basis of the
procedure and region:
Procedure Outlook
(Revenue, USD Million, 2012 - 2022)
- Fresh Donor
- Fresh Non-donor
- Frozen Donor
- Frozen Non-donor
- Embryo/Egg Banking
Regional Outlook
(Revenue, USD Million, 2012 - 2022)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- Middle East and Africa
- South Africa
About Grand View
Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research reports,
and consulting services. To help clients make informed business decisions, we
offer market intelligence studies ensuring relevant and fact-based research
across a range of industries, from technology to chemicals, materials and
healthcare.
No comments:
Post a Comment